JP Morgan Chase
STIM icon

JP Morgan Chase’s Neuronetics STIM Stock Holding History

JP Morgan Chase’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,800
Closed -$4.91K – 7759
2025
Q3 		$4.91K Buy
+1,800
New +$6.39K ﹤0.01% 6782

Other funds holding STIM

MAM
Madryn Asset Management New York $36.9M AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase's STIM Position: Q2 2026 in Review

JP Morgan Chase reduced its Neuronetics (STIM) stake by 97% in Q2 2026, selling an estimated $30.1K and leaving 748 shares worth $1.02K. The position accounts for ﹤0.01% of the portfolio, ranked #7325.

JP Morgan Chase first reported a position in STIM in Q3 2018 and has held it in 32 quarters since. The position peaked at $1.5M in Q1 2019. 87 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • JP Morgan Chase held 748 shares of Neuronetics worth $1.02K as of Q2 2026.
  • JP Morgan Chase sold 20,681 Neuronetics shares in Q2 2026, an estimated $30.1K.
  • Neuronetics made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #7325 holding.
  • JP Morgan Chase first reported a position in Neuronetics in Q3 2018 and has held it in 32 quarters since.
  • JP Morgan Chase's Neuronetics position peaked at $1.5M in Q1 2019.
  • 87 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.